SCOPUS 정보 검색 플랫폼

Science Signaling

Volumn 2, Issue 93, 2009, Pages

G protein-coupled receptors, cholinergic dysfunction, and Aβ toxicity in alzheimer's disease

(2) Thathiah, Amantha a,b De Strooper, Bart a,b

a DEPARTMENT OF PLANT SYSTEMS BIOLOGY (Belgium)

b UNIVERSITY OF LEUVEN (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC RECEPTOR; TAU PROTEIN;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; CHOLINERGIC SYSTEM; CLINICAL ASSESSMENT; HYPOTHESIS; MICROTUBULE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HUMANS; OXIDATIVE STRESS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

EID: 77952351441 PISSN: 19450877 EISSN: 19379145 Source Type: Journal
DOI: 10.1126/scisignal.293re8 Document Type: Review

Times cited : (48)

References (101)

1
- 34250819839
- Intracellular amyloid-β in Alzheimer's disease
- F. M. LaFerla, K. N. Green, S. Oddo, Intracellular amyloid-β in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509 (2007).
- (2007) Nat. Rev. Neurosci. , vol.8 , pp. 499-509
- LaFerla, F.M.¹ Green, K.N.² Oddo, S.³

2
- 0035066332
- Alzheimer's disease: Genes, proteins, and therapy
- D. J. Selkoe, Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 81, 741-766 (2001).
- (2001) Physiol. Rev. , vol.81 , pp. 741-766
- Selkoe, D.J.¹

3
- 0037135111
- The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
- J. Hardy, D. J. Selkoe, The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
- (2002) Science , vol.297 , pp. 353-356
- Hardy, J.¹ Selkoe, D.J.²

4
- 0019972810
- The cholinergic hypothesis of geriatric memory dysfunction
- R. T. Bartus, R. L. Dean 3rd, B. Beer, A. S. Lippa, The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414 (1982).
- (1982) Science , vol.217 , pp. 408-414
- Bartus, R.T.¹ Dean III, R.L.² Beer, B.³ Lippa, A.S.⁴

5
- 0037431082
- Aph-1 Pen-2 and Nicastrin with Presenilin generate an active ã-Secretase complex
- B. De Strooper, Aph-1, Pen-2, and Nicastrin with Presenilin generate an active ã-Secretase complex. Neuron 38, 9-12 (2003).
- (2003) Neuron , vol.38 , pp. 9-12
- De Strooper, B.¹

6
- 55949117032
- Frequent amyloid deposition without significant cognitive impairment among the elderly
- H. J. Aizenstein, R. D. Nebes, J. A. Saxton, J. C. Price, C. A. Mathis, N. D. Tsopelas, S. K. Ziolko, J. A. James, B. E. Snitz, P. R. Houck, W. Bi, A. D. Cohen, B. J. Lopresti, S. T. DeKosky, E. M. Halligan, W. E. Klunk, Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 65, 1509-1517 (2008).
- (2008) Arch. Neurol. , vol.65 , pp. 1509-1517
- Aizenstein, H.J.¹ Nebes, R.D.² Saxton, J.A.³ Price, J.C.⁴ Mathis, C.A.⁵ Tsopelas, N.D.⁶ Ziolko, S.K.⁷ James, J.A.⁸ Snitz, B.E.⁹ Houck, P.R.¹⁰ Bi, W.¹¹ Cohen, A.D.¹² Lopresti, B.J.¹³ DeKosky, S.T.¹⁴ Halligan, E.M.¹⁵ Klunk, W.E.¹⁶

7
- 33644832047
- 42 in humans
- 42 in humans. Ann. Neurol. 59, 512-519 (2006).
- (2006) Ann. Neurol. , vol.59 , pp. 512-519
- Fagan, A.M.¹ Mintun, M.A.² Mach, R.H.³ Lee, S.Y.⁴ Dence, C.S.⁵ Shah, A.R.⁶ LaRossa, G.N.⁷ Spinner, M.L.⁸ Klunk, W.E.⁹ Mathis, C.A.¹⁰ DeKosky, S.T.¹¹ Morris, J.C.¹² Holtzman, D.M.¹³

8
- 35648932901
- β-Amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease
- K. E. Pike, G. Savage, V. L. Villemagne, S. Ng, S. A. Moss, P. Maruff, C. A. Mathis, W. E. Klunk, C. L. Masters, C. C. Rowe, β-Amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain 130, 2837-2844 (2007).
- (2007) Brain , vol.130 , pp. 2837-2844
- Pike, K.E.¹ Savage, G.² Villemagne, V.L.³ Ng, S.⁴ Moss, S.A.⁵ Maruff, P.⁶ Mathis, C.A.⁷ Klunk, W.E.⁸ Masters, C.L.⁹ Rowe, C.C.¹⁰

9
- 0033358671
- Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum
- D. Campion, C. Dumanchin, D. Hannequin, B. Dubois, S. Belliard, M. Puel, C. Thomas-Anterion, A. Michon, C. Martin, F. Charbonnier, G. Raux, A. Camuzat, C. Penet, V. Mesnage, M. Martinez, F. Clerget-Darpoux, A. Brice, T. Frebourg, Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 65, 664-670 (1999).
- (1999) Am. J. Hum. Genet. , vol.65 , pp. 664-670
- Campion, D.¹ Dumanchin, C.² Hannequin, D.³ Dubois, B.⁴ Belliard, S.⁵ Puel, M.⁶ Thomas-Anterion, C.⁷ Michon, A.⁸ Martin, C.⁹ Charbonnier, F.¹⁰ Raux, G.¹¹ Camuzat, A.¹² Penet, C.¹³ Mesnage, V.¹⁴ Martinez, M.¹⁵ Clerget-Darpoux, F.¹⁶ Brice, A.¹⁷ Frebourg, T.¹⁸

10
- 38049056730
- Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice
- I. C. Martins, I. Kuperstein, H. Wilkinson, E. Maes, M. Vanbrabant, W. Jonckheere, P. Van Gelder, D. Hartmann, R. D'Hooge, B. De Strooper, J. Schymkowitz, F. Rousseau, Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 27, 224-233 (2008).
- (2008) EMBO J. , vol.27 , pp. 224-233
- Martins, I.C.¹ Kuperstein, I.² Wilkinson, H.³ Maes, E.⁴ Vanbrabant, M.⁵ Jonckheere, W.⁶ Van Gelder, P.⁷ Hartmann, D.⁸ D'Hooge, R.⁹ De Strooper, B.¹⁰ Schymkowitz, J.¹¹ Rousseau, F.¹²

11
- 44549087765
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
- D. J. Selkoe, Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106-113 (2008).
- (2008) Behav. Brain Res. , vol.192 , pp. 106-113
- Selkoe, D.J.¹

12
- 0242424155
- Self-assembly of Aβ1-42 into globular neurotoxins
- B. A. Chromy, R. J. Nowak, M. P. Lambert, K. L. Viola, L. Chang, P. T. Velasco, B. W. Jones, S. J. Fernandez, P. N. Lacor, P. Horowitz, C. E. Finch, G. A. Krafft, W. L. Klein, Self-assembly of Aβ1-42 into globular neurotoxins. Biochemistry 42, 12749-12760 (2003).
- (2003) Biochemistry , vol.42 , pp. 12749-12760
- Chromy, B.A.¹ Nowak, R.J.² Lambert, M.P.³ Viola, K.L.⁴ Chang, L.⁵ Velasco, P.T.⁶ Jones, B.W.⁷ Fernandez, S.J.⁸ Lacor, P.N.⁹ Horowitz, P.¹⁰ Finch, C.E.¹¹ Krafft, G.A.¹² Klein, W.L.¹³

13
- 33645038471
- A specific amyloid-β protein assembly in the brain impairs memory
- S. Lesne, M. T. Koh, L. Kotilinek, R. Kayed, C. G. Glabe, A.Yang, M. Gallagher, K. H. Ashe, A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357 (2006).
- (2006) Nature , vol.440 , pp. 352-357
- Lesne, S.¹ Koh, M.T.² Kotilinek, L.³ Kayed, R.⁴ Glabe, C.G.⁵ Yang, A.⁶ Gallagher, M.⁷ Ashe, K.H.⁸

14
- 0032539975
- Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red
- M. B. Podlisny, D. M.Walsh, P. Amarante, B. L. Ostaszewski, E. R. Stimson, J. E. Maggio, D. B. Teplow, D. J. Selkoe, Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry 37, 3602-3611 (1998).
- (1998) Biochemistry , vol.37 , pp. 3602-3611
- Podlisny, M.B.¹ Walsh, D.M.² Amarante, P.³ Ostaszewski, B.L.⁴ Stimson, E.R.⁵ Maggio, J.E.⁶ Teplow, D.B.⁷ Selkoe, D.J.⁸

15
- 0042838303
- Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
- Y. Gong, L. Chang, K. L. Viola, P. N. Lacor, M. P. Lambert, C. E. Finch, G. A. Krafft, W. L. Klein, Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U.S.A. 100, 10417-10422 (2003).
- (2003) Proc. Natl. Acad. Sci. U.S.A. , vol.100 , pp. 10417-10422
- Gong, Y.¹ Chang, L.² Viola, K.L.³ Lacor, P.N.⁴ Lambert, M.P.⁵ Finch, C.E.⁶ Krafft, G.A.⁷ Klein, W.L.⁸

16
- 11544279355
- Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
- M. P. Lambert, A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft, W. L. Klein, Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453 (1998).
- (1998) Proc. Natl. Acad. Sci. U.S.A. , vol.95 , pp. 6448-6453
- Lambert, M.P.¹ Barlow, A.K.² Chromy, B.A.³ Edwards, C.⁴ Freed, R.⁵ Liosatos, M.⁶ Morgan, T.E.⁷ Rozovsky, I.⁸ Trommer, B.⁹ Viola, K.L.¹⁰ Wals, P.¹¹ Zhang, C.¹² Finch, C.E.¹³ Krafft, G.A.¹⁴ Klein, W.L.¹⁵

17
- 0037041426
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
- D. M. Walsh, I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl, M. S.Wolfe, M. J. Rowan, D. J. Selkoe, Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539 (2002).
- (2002) Nature , vol.416 , pp. 535-539
- Walsh, D.M.¹ Klyubin, I.² Fadeeva, J.V.³ Cullen, W.K.⁴ Anwyl, R.⁵ Wolfe, M.S.⁶ Rowan, M.J.⁷ Selkoe, D.J.⁸

18
- 22544482926
- 42 is essential for parenchymal and vascular amyloid deposition in mice
- 42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199 (2005).
- (2005) Neuron , vol.47 , pp. 191-199
- McGowan, E.¹ Pickford, F.² Kim, J.³ Onstead, L.⁴ Eriksen, J.⁵ Yu, C.⁶ Skipper, L.⁷ Murphy, M.P.⁸ Beard, J.⁹ Das, P.¹⁰ Jansen, K.¹¹ Delucia, M.¹² Lin, W.L.¹³ Dolios, G.¹⁴ Wang, R.¹⁵ Eckman, C.B.¹⁶ Dickson, D.W.¹⁷ Hutton, M.¹⁸ Hardy, J.¹⁹ Golde, T.²⁰ more..

19
- 33645105621
- Presenilin clinical mutations can affect ã-secretase activity by different mechanisms
- M. Bentahir, O. Nyabi, J. Verhamme, A. Tolia, K. Horre, J. Wiltfang, H. Esselmann, B. De Strooper, Presenilin clinical mutations can affect ã-secretase activity by different mechanisms. J. Neurochem. 96, 732-742 (2006).
- (2006) J. Neurochem. , vol.96 , pp. 732-742
- Bentahir, M.¹ Nyabi, O.² Verhamme, J.³ Tolia, A.⁴ Horre, K.⁵ Wiltfang, J.⁶ Esselmann, H.⁷ De Strooper, B.⁸

20
- 33947201115
- Loss-of-function presenilin mutations in Alzheimer disease: Talking point on the role of presenilin mutations in Alzheimer disease
- B. De Strooper, Loss-of-function presenilin mutations in Alzheimer disease: Talking point on the role of presenilin mutations in Alzheimer disease. EMBO Rep. 8, 141-146 (2007).
- (2007) EMBO Rep. , vol.8 , pp. 141-146
- De Strooper, B.¹

21
- 33947242870
- 42/Aβ40: Talking point on the role of presenilin mutations in Alzheimer disease
- 42/Aβ40: Talking point on the role of presenilin mutations in Alzheimer disease. EMBO Rep. 8, 136-140 (2007).
- (2007) EMBO Rep. , vol.8 , pp. 136-140
- Wolfe, M.S.¹

22
- 33847239940
- Structural principles of tau and the paired helical filaments of Alzheimer's disease
- E. Mandelkow, M. von Bergen, J. Biernat, E. M. Mandelkow, Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain Pathol. 17, 83-90 (2007).
- (2007) Brain Pathol. , vol.17 , pp. 83-90
- Mandelkow, E.¹ Von Bergen, M.² Biernat, J.³ Mandelkow, E.M.⁴

23
- 34548036227
- Taumediated neurodegeneration in Alzheimer's disease and related disorders
- C. Ballatore, V. M. Lee, J. Q. Trojanowski, Taumediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663-672 (2007).
- (2007) Nat. Rev. Neurosci. , vol.8 , pp. 663-672
- Ballatore, C.¹ Lee, V.M.² Trojanowski, J.Q.³

24
- 61849088424
- Tau phosphorylation: The therapeutic challenge for neurodegenerative disease
- D. P. Hanger, B. H. Anderton, W. Noble, Tau phosphorylation: The therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 15, 112-119 (2009).
- (2009) Trends Mol. Med. , vol.15 , pp. 112-119
- Hanger, D.P.¹ Anderton, B.H.² Noble, W.³

25
- 0037126688
- Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments
- S. Barghorn, E. Mandelkow, Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 41, 14885-14896 (2002).
- (2002) Biochemistry , vol.41 , pp. 14885-14896
- Barghorn, S.¹ Mandelkow, E.²

26
- 0036810492
- Functions and malfunctions of the tau proteins
- N. Shahani, R. Brandt, Functions and malfunctions of the tau proteins. Cell. Mol. Life Sci. 59, 1668-1680 (2002).
- (2002) Cell. Mol. Life Sci. , vol.59 , pp. 1668-1680
- Shahani, N.¹ Brandt, R.²

27
- 0032904563
- Cognitive functions of the basal forebrain
- M. G. Baxter, A. A. Chiba, Cognitive functions of the basal forebrain. Curr. Opin. Neurobiol. 9, 178-183 (1999).
- (1999) Curr. Opin. Neurobiol. , vol.9 , pp. 178-183
- Baxter, M.G.¹ Chiba, A.A.²

28
- 0021044702
- Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1-Ch6)
- M. M. Mesulam, E. J. Mufson, B. H.Wainer, A. I. Levey, Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10, 1185-1201 (1983).
- (1983) Neuroscience , vol.10 , pp. 1185-1201
- Mesulam, M.M.¹ Mufson, E.J.² Wainer, B.H.³ Levey, A.I.⁴

29
- 46749118974
- Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease
- A. Fisher, Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease. Neurotherapeutics 5, 433-442 (2008).
- (2008) Neurotherapeutics , vol.5 , pp. 433-442
- Fisher, A.¹

30
- 0031821608
- Pharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited
- C. J. Ladner, J. M. Lee, Pharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited. J. Neuropathol. Exp. Neurol. 57, 719-731 (1998).
- (1998) J. Neuropathol. Exp. Neurol. , vol.57 , pp. 719-731
- Ladner, C.J.¹ Lee, J.M.²

31
- 0030297372
- The critical role of cholinergic basal forebrain neurons in morphological change and memory encoding: A hypothesis
- N. J. Woolf, The critical role of cholinergic basal forebrain neurons in morphological change and memory encoding: A hypothesis. Neurobiol. Learn. Mem. 66, 258-266 (1996).
- (1996) Neurobiol. Learn. Mem. , vol.66 , pp. 258-266
- Woolf, N.J.¹

32
- 0025943814
- Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies
- A. I. Levey, C. A. Kitt, W. F. Simonds, D. L. Price, M. R. Brann, Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11, 3218-3226 (1991).
- (1991) J. Neurosci. , vol.11 , pp. 3218-3226
- Levey, A.I.¹ Kitt, C.A.² Simonds, W.F.³ Price, D.L.⁴ Brann, M.R.⁵

33
- 0028169478
- M1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC
- J.Wei, E. A.Walton, A. Milici, J. J. Buccafusco, m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J. Neurochem. 63, 815-821 (1994).
- (1994) J. Neurochem. , vol.63 , pp. 815-821
- Wei, J.¹ Walton, E.A.² Milici, A.³ Buccafusco, J.J.⁴

34
- 0021797563
- Neurochemical studies of early-onset Alzheimer's disease: Possible influence on treatment
- P. T. Francis, A. M. Palmer, N. R. Sims, D. M. Bowen, A. N. Davison, M. M. Esiri, D. Neary, J. S. Snowden, G. K. Wilcock, Neurochemical studies of early-onset Alzheimer's disease: Possible influence on treatment. N. Engl. J. Med. 313, 7-11 (1985).
- (1985) N. Engl. J. Med. , vol.313 , pp. 7-11
- Francis, P.T.¹ Palmer, A.M.² Sims, N.R.³ Bowen, D.M.⁴ Davison, A.N.⁵ Esiri, M.M.⁶ Neary, D.⁷ Snowden, J.S.⁸ Wilcock, G.K.⁹

35
- 0021962590
- Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation
- D. C. Mash, D. D. Flynn, L. T. Potter, Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228, 1115-1117 (1985).
- (1985) Science , vol.228 , pp. 1115-1117
- Mash, D.C.¹ Flynn, D.D.² Potter, L.T.³

36
- 84886631402
- Neurotransmitter enzyme abnormalities in senile dementia: Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue
- E. K. Perry, P. H. Gibson, G. Blessed, R. H. Perry, B. E. Tomlinson, Neurotransmitter enzyme abnormalities in senile dementia: Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci. 34, 247-265 (1977).
- (1977) J. Neurol. Sci. , vol.34 , pp. 247-265
- Perry, E.K.¹ Gibson, P.H.² Blessed, G.³ Perry, R.H.⁴ Tomlinson, B.E.⁵

37
- 0032985064
- Lesion of septal-hippocampal neurons with 192 IgGsaporin alters function of M1 muscarinic receptors
- P. E. Potter, C. Gaughan, Y. Assouline, Lesion of septal-hippocampal neurons with 192 IgGsaporin alters function of M1 muscarinic receptors. Neuropharmacology 38, 579-586 (1999).
- (1999) Neuropharmacology , vol.38 , pp. 579-586
- Potter, P.E.¹ Gaughan, C.² Assouline, Y.³

38
- 33746210128
- Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease
- S.W. Tsang, M. K. Lai, S. Kirvell, P. T. Francis, M. M. Esiri, T. Hope, C. P. Chen, P. T. Wong, Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. Neurobiol. Aging 27, 1216-1223 (2006).
- (2006) Neurobiol. Aging , vol.27 , pp. 1216-1223
- Tsang, S.W.¹ Lai, M.K.² Kirvell, S.³ Francis, P.T.⁴ Esiri, M.M.⁵ Hope, T.⁶ Chen, C.P.⁷ Wong, P.T.⁸

39
- 0028925434
- Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: Implications for cholinergic-based therapies
- D. D. Flynn, G. Ferrari-DiLeo, A. I. Levey, D. C. Mash, Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: Implications for cholinergic-based therapies. Life Sci. 56, 869-876 (1995).
- (1995) Life Sci. , vol.56 , pp. 869-876
- Flynn, D.D.¹ Ferrari-DiLeo, G.² Levey, A.I.³ Mash, D.C.⁴

40
- 0035892543
- Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study
- K. Shiozaki, E. Iseki, H. Hino, K. Kosaka, Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study. J. Neurol. Sci. 193, 23-28 (2001).
- (2001) J. Neurol. Sci. , vol.193 , pp. 23-28
- Shiozaki, K.¹ Iseki, E.² Hino, H.³ Kosaka, K.⁴

41
- 0026485448
- Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists
- A. L. Svensson, I. Alafuzoff, A. Nordberg, Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists. Brain Res. 596, 142-148 (1992).
- (1992) Brain Res. , vol.596 , pp. 142-148
- Svensson, A.L.¹ Alafuzoff, I.² Nordberg, A.³

42
- 0029936331
- Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins
- J. H. Exton, Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36, 481-509 (1996).
- (1996) Annu. Rev. Pharmacol. Toxicol. , vol.36 , pp. 481-509
- Exton, J.H.¹

43
- 0032530817
- Activation of the genetically defined m1 muscarinic receptor potentiates Nmethyl- D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells
- M. J. Marino, S. T. Rouse, A. I. Levey, L. T. Potter, P. J. Conn, Activation of the genetically defined m1 muscarinic receptor potentiates Nmethyl- D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U.S.A. 95, 11465-11470 (1998).
- (1998) Proc. Natl. Acad. Sci. U.S.A. , vol.95 , pp. 11465-11470
- Marino, M.J.¹ Rouse, S.T.² Levey, A.I.³ Potter, L.T.⁴ Conn, P.J.⁵

44
- 0037220723
- Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice
- S. G. Anagnostaras, G. G. Murphy, S. E. Hamilton, S. L. Mitchell, N. P. Rahnama, N. M. Nathanson, A. J. Silva, Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat. Neurosci. 6, 51-58 (2003).
- (2003) Nat. Neurosci. , vol.6 , pp. 51-58
- Anagnostaras, S.G.¹ Murphy, G.G.² Hamilton, S.E.³ Mitchell, S.L.⁴ Rahnama, N.P.⁵ Nathanson, N.M.⁶ Silva, A.J.⁷

45
- 0025969654
- Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies
- D. D. Flynn, D. A. Weinstein, D. C. Mash, Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies. Ann. Neurol. 29, 256-262 (1991).
- (1991) Ann. Neurol. , vol.29 , pp. 256-262
- Flynn, D.D.¹ Weinstein, D.A.² Mash, D.C.³

46
- 0023620323
- Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain-a preliminary study in Alzheimer's disease
- C. J. Smith, E. K. Perry, R. H. Perry, A. F. Fairbairn, N. J. Birdsall, Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain-a preliminary study in Alzheimer's disease. Neurosci. Lett. 82, 227-232 (1987).
- (1987) Neurosci. Lett. , vol.82 , pp. 227-232
- Smith, C.J.¹ Perry, E.K.² Perry, R.H.³ Fairbairn, A.F.⁴ Birdsall, N.J.⁵

47
- 0027258552
- Coupling of muscarinic receptors to GTP proteins in postmortem human brain-alterations in Alzheimer's disease
- U. Warpman, I. Alafuzoff, A. Nordberg, Coupling of muscarinic receptors to GTP proteins in postmortem human brain-alterations in Alzheimer's disease. Neurosci. Lett. 150, 39-43 (1993).
- (1993) Neurosci. Lett. , vol.150 , pp. 39-43
- Warpman, U.¹ Alafuzoff, I.² Nordberg, A.³

48
- 0025989976
- Coupling of m1 muscarinic receptors to G protein in Alzheimer disease
- B. D. Pearce, L. T. Potter, Coupling of m1 muscarinic receptors to G protein in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 5, 163-172 (1991).
- (1991) Alzheimer Dis. Assoc. Disord. , vol.5 , pp. 163-172
- Pearce, B.D.¹ Potter, L.T.²

49
- 0027461308
- Transmembrane signaling through phospholipase C in human cortical membranes
- M. A. Wallace, E. Claro, Transmembrane signaling through phospholipase C in human cortical membranes. Neurochem. Res. 18, 139-145 (1993). (Pubitemid 23067755)
- (1993) Neurochemical Research , vol.18 , Issue.2 , pp. 139-145
- Wallace, M.A.¹ Claro, E.²

50
- 0028981972
- Phosphoinositide hydrolysis, Gáq, phospholipase C, and protein kinase C in post mortem human brain: Effects of post mortem interval, subject age, and Alzheimer's disease
- A. F. Greenwood, R. E. Powers, R. S. Jope, Phosphoinositide hydrolysis, Gáq, phospholipase C, and protein kinase C in post mortem human brain: Effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience 69, 125-138 (1995).
- (1995) Neuroscience , vol.69 , pp. 125-138
- Greenwood, A.F.¹ Powers, R.E.² Jope, R.S.³

51
- 0031051353
- Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain
- DOI 10.1016/S0197-4580(96)00205-9, PII S0197458096002059
- R. S. Jope, L. Song, R. E. Powers, Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain. Neurobiol. Aging 18, 111-120 (1997). (Pubitemid 27062193)
- (1997) Neurobiology of Aging , vol.18 , Issue.1 , pp. 111-120
- Jope, R.S.¹ Song, L.² Powers, R.E.³

52
- 0029145375
- A neurochemical approach for studying response to acetylcholine in Alzheimer's disease
- J. T. Alder, I. P. Chessell, D. M. Bowen, A neurochemical approach for studying response to acetylcholine in Alzheimer's disease. Neurochem. Res. 20, 769-771 (1995).
- (1995) Neurochem. Res. , vol.20 , pp. 769-771
- Alder, J.T.¹ Chessell, I.P.² Bowen, D.M.³

53
- 0029950633
- The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain
- R. S. Jope, L. Song, P. P. Li, L. T. Young, S. J. Kish, M. A. Pacheco, J. J. Warsh, The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J. Neurochem. 66, 2402-2409 (1996). (Pubitemid 26159075)
- (1996) Journal of Neurochemistry , vol.66 , Issue.6 , pp. 2402-2409
- Jope, R.S.¹ Song, L.² Li, P.P.³ Young, L.T.⁴ Kish, S.J.⁵ Pacheco, M.A.⁶ Warsh, J.J.⁷

54
- 0030271610
- Phosphoinositide signaling in human brain
- M. A. Pacheco, R. S. Jope, Phosphoinositide signaling in human brain. Prog. Neurobiol. 50, 255-273 (1996).
- (1996) Prog. Neurobiol. , vol.50 , pp. 255-273
- Pacheco, M.A.¹ Jope, R.S.²

55
- 0028343627
- Impaired phosphoinositide hydrolysis in Alzheimer's disease brain
- DOI 10.1016/0197-4580(94)90116-3
- R. S. Jope, L. Song, X. Li, R. Powers, Impaired phosphoinositide hydrolysis in Alzheimer's disease brain. Neurobiol. Aging 15, 221-226 (1994). (Pubitemid 24120830)
- (1994) Neurobiology of Aging , vol.15 , Issue.2 , pp. 221-226
- Jope, R.S.¹ Song, L.² Li, X.³ Powers, R.⁴

56
- 0042332177
- G-protein a-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimer's disease neurofibrillary and amyloid pathologies
- DOI 10.1097/00001756-200308060-00025
- A. García-Jiménez, J. Fastbom, T. G. Ohm, R. F. Cowburn, G-protein á-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimer's disease neurofibrillary and amyloid pathologies. Neuroreport 14, 1523-1527 (2003). (Pubitemid 37083142)
- (2003) NeuroReport , vol.14 , Issue.11 , pp. 1523-1527
- Garcia-Jimenez, A.¹ Fastbom, J.² Ohm, T.G.³ Cowburn, R.F.⁴

57
- 0030071040
- Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain
- DOI 10.1016/0197-4580(95)02023-3
- X. Li, A. F. Greenwood, R. Powers, R. S. Jope, Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain. Neurobiol. Aging 17, 115-122 (1996). (Pubitemid 26019102)
- (1996) Neurobiology of Aging , vol.17 , Issue.1 , pp. 115-122
- Li, X.¹ Greenwood, A.F.² Powers, R.³ Jope, R.S.⁴

58
- 0036813653
- Group I metabotropic glutamate receptor signaling via Gaq/Ga11 secures the induction of long-term potentiation in the hippocampal area CA1
- M. Miura, M. Watanabe, S. Offermanns, M. I. Simon, M. Kano, Group I metabotropic glutamate receptor signaling via Gáq/Gá11 secures the induction of long-term potentiation in the hippocampal area CA1. J. Neurosci. 22, 8379-8390 (2002). (Pubitemid 35387578)
- (2002) Journal of Neuroscience , vol.22 , Issue.19 , pp. 8379-8390
- Miura, M.¹ Watanabe, M.² Offermanns, S.³ Simon, M.I.⁴ Kano, M.⁵

59
- 33746513147
- 11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation
- DOI 10.1128/MCB.00397-06
- N. Wettschureck, M. van der Stelt, H. Tsubokawa, H. Krestel, A. Moers, S. Petrosino, G. Schutz, V. Di Marzo, S. Offermanns, Forebrain- specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation. Mol. Cell. Biol. 26, 5888-5894 (2006). (Pubitemid 44134342)
- (2006) Molecular and Cellular Biology , vol.26 , Issue.15 , pp. 5888-5894
- Wettschureck, N.¹ Van Der Stelt, M.² Tsubokawa, H.³ Krestel, H.⁴ Moers, A.⁵ Petrosino, S.⁶ Schutz, G.⁷ Di Marzo, V.⁸ Offermanns, S.⁹

60
- 58049191392
- Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease
- T. Watanabe, N. Yamagata, K. Takasaki, K. Sano, K. Hayakawa, S. Katsurabayashi, N. Egashira, K. Mishima, K. Iwasaki, M. Fujiwara, Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res. 1249, 222-228 (2009).
- (2009) Brain Res. , vol.1249 , pp. 222-228
- Watanabe, T.¹ Yamagata, N.² Takasaki, K.³ Sano, K.⁴ Hayakawa, K.⁵ Katsurabayashi, S.⁶ Egashira, N.⁷ Mishima, K.⁸ Iwasaki, K.⁹ Fujiwara, M.¹⁰

61
- 64549132538
- M1 agonists as a potential disease-modifying therapy for Alzheimer's disease
- A. Caccamo, A. Fisher, F. M. LaFerla, M1 agonists as a potential disease-modifying therapy for Alzheimer's disease. Curr. Alzheimer Res. 6, 112-117 (2009).
- (2009) Curr. Alzheimer Res. , vol.6 , pp. 112-117
- Caccamo, A.¹ Fisher, A.² LaFerla, F.M.³

62
- 14644442872
- Intraneuronal Ab causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
- DOI 10.1016/j.neuron.2005.01.040
- L. M. Billings, S. Oddo, K. N. Green, J. L. Mc- Gaugh, F. M. LaFerla, Intraneuronal Aβ causes the onset of early Alzheimer's diseaserelated cognitive deficits in transgenic mice. Neuron 45, 675-688 (2005). (Pubitemid 40320703)
- (2005) Neuron , vol.45 , Issue.5 , pp. 675-688
- Billings, L.M.¹ Oddo, S.² Green, K.N.³ McGaugh, J.L.⁴ LaFerla, F.M.⁵

63
- 14544304591
- Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease
- DOI 10.1073/pnas.0408500102
- S. Oddo, A. Caccamo, K. N. Green, K. Liang, L. Tran, Y. Chen, F. M. Leslie, F. M. LaFerla, Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 102, 3046-3051 (2005). (Pubitemid 40299913)
- (2005) Proceedings of the National Academy of Sciences of the United States of America , vol.102 , Issue.8 , pp. 3046-3051
- Oddo, S.¹ Caccamo, A.² Green, K.N.³ Liang, K.⁴ Tran, L.⁵ Chen, Y.⁶ Leslie, F.M.⁷ LaFerla, F.M.⁸

64
- 0042697305
- Triple-transgenic model of Alzheimer's Disease with plaques and tangles: Intracellular Ab and synaptic dysfunction
- DOI 10.1016/S0896-6273(03)00434-3
- S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, F. M. LaFerla, Tripletransgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421 (2003). (Pubitemid 36937044)
- (2003) Neuron , vol.39 , Issue.3 , pp. 409-421
- Oddo, S.¹ Caccamo, A.² Shepherd, J.D.³ Murphy, M.P.⁴ Golde, T.E.⁵ Kayed, R.⁶ Metherate, R.⁷ Mattson, M.P.⁸ Akbari, Y.⁹ LaFerla, F.M.¹⁰

65
- 33344458827
- M1 receptors play a central role in modulating AD-like pathology in transgenic mice
- DOI 10.1016/j.neuron.2006.01.020, PII S0896627306000730
- A. Caccamo, S. Oddo, L. M. Billings, K. N. Green, H. Martinez-Coria, A. Fisher, F. M. LaFerla, M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49, 671-682 (2006). (Pubitemid 43290127)
- (2006) Neuron , vol.49 , Issue.5 , pp. 671-682
- Caccamo, A.¹ Oddo, S.² Billings, L.M.³ Green, K.N.⁴ Martinez-Coria, H.⁵ Fisher, A.⁶ LaFerla, F.M.⁷

66
- 55249118679
- Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats
- C. K. Jones, A. E. Brady, A. A. Davis, Z. Xiang, M. Bubser, M. N. Tantawy, A. S. Kane, T. M. Bridges, J. P. Kennedy, S. R. Bradley, T. E. Peterson, M. S. Ansari, R. M. Baldwin, R. M. Kessler, A. Y. Deutch, J. J. Lah, A. I. Levey, C. W. Lindsley, P. J. Conn, Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. J. Neurosci. 28, 10422-10433 (2008).
- (2008) J. Neurosci. , vol.28 , pp. 10422-10433
- Jones, C.K.¹ Brady, A.E.² Davis, A.A.³ Xiang, Z.⁴ Bubser, M.⁵ Tantawy, M.N.⁶ Kane, A.S.⁷ Bridges, T.M.⁸ Kennedy, J.P.⁹ Bradley, S.R.¹⁰ Peterson, T.E.¹¹ Ansari, M.S.¹² Baldwin, R.M.¹³ Kessler, R.M.¹⁴ Deutch, A.Y.¹⁵ Lah, J.J.¹⁶ Levey, A.I.¹⁷ Lindsley, C.W.¹⁸ Conn, P.J.¹⁹

67
- 58549096688
- Amyloid-β causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons
- T. Chiba, M. Yamada, J. Sasabe, K. Terashita, M. Shimoda, M. Matsuoka, S. Aiso, Amyloid-β causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol. Psychiatry 14, 206-222 (2009).
- (2009) Mol. Psychiatry , vol.14 , pp. 206-222
- Chiba, T.¹ Yamada, M.² Sasabe, J.³ Terashita, K.⁴ Shimoda, M.⁵ Matsuoka, M.⁶ Aiso, S.⁷

68
- 34347374690
- Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: Parthenolide targets JAK1 activation by generating ROS
- DOI 10.1002/jcp.21033
- M. Kurdi, G. W. Booz, Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: Parthenolide targets JAK1 activation by generating ROS. J. Cell. Physiol. 212, 424-431 (2007). (Pubitemid 47025632)
- (2007) Journal of Cellular Physiology , vol.212 , Issue.2 , pp. 424-431
- Kurdi, M.¹ Booz, G.W.²

69
- 0346122900
- Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma
- DOI 10.1038/sj.onc.1207170
- T. Hideshima, D. Chauhan, T. Hayashi, M. Akiyama, N. Mitsiades, C. Mitsiades, K. Podar, N. C. Munshi, P. G. Richardson, K. C. Anderson, Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase- dependent downregulation of gp130 in multiple myeloma. Oncogene 22, 8386-8393 (2003). (Pubitemid 37523890)
- (2003) Oncogene , vol.22 , Issue.52 , pp. 8386-8393
- Hideshima, T.¹ Chauhan, D.² Hayashi, T.³ Akiyama, M.⁴ Mitsiades, N.⁵ Mitsiades, C.⁶ Podar, K.⁷ Munshi, N.C.⁸ Richardson, P.G.⁹ Anderson, K.C.¹⁰

70
- 71349085957
- Defects in IGF- 1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- 10.1016/j.neurobiolaging.2008.04.002, published online 13 May
- A. M. Moloney, R. J. Griffin, S. Timmons, R. O'Connor, R. Ravid, C. O'Neill, Defects in IGF- 1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging, 10.1016/j.neurobiolaging.2008.04.002, published online 13 May 2008.
- (2008) Neurobiol. Aging
- Moloney, A.M.¹ Griffin, R.J.² Timmons, S.³ O'Connor, R.⁴ Ravid, R.⁵ O'Neill, C.⁶

71
- 39049161519
- Angiotensin receptor subtype mediated physiologies and behaviors: New discoveries and clinical targets
- J. W. Wright, B. J. Yamamoto, J. W. Harding, Angiotensin receptor subtype mediated physiologies and behaviors: New discoveries and clinical targets. Prog. Neurobiol. 84, 157-181 (2008).
- (2008) Prog. Neurobiol. , vol.84 , pp. 157-181
- Wright, J.W.¹ Yamamoto, B.J.² Harding, J.W.³

72
- 0028858478
- Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
- T. Ichiki, P. A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. L. Hogan, T. Inagami, Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377, 748-750 (1995).
- (1995) Nature , vol.377 , pp. 748-750
- Ichiki, T.¹ Labosky, P.A.² Shiota, C.³ Okuyama, S.⁴ Imagawa, Y.⁵ Fogo, A.⁶ Niimura, F.⁷ Ichikawa, I.⁸ Hogan, B.L.⁹ Inagami, T.¹⁰

73
- 0032920523
- Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain
- DOI 10.1210/en.140.1.500
- U. V. Shenoy, E. M. Richards, X. C. Huang, C. Sumners, Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain. Endocrinology 140, 500-509 (1999). (Pubitemid 29011197)
- (1999) Endocrinology , vol.140 , Issue.1 , pp. 500-509
- Shenoy, U.V.¹ Richards, E.M.² Huang, X.-C.³ Sumners, C.⁴

74
- 0037189325
- AGTR2 mutations in X-linked mental retardation
- V. S. Vervoort, M. A. Beachem, P. S. Edwards, S. Ladd, K. E. Miller, X. de Mollerat, K. Clarkson, B. DuPont, C. E. Schwartz, R. E. Stevenson, E. Boyd, A. K. Srivastava, AGTR2 mutations in X-linked mental retardation. Science 296, 2401-2403 (2002). (Pubitemid 34734216)
- (2002) Science , vol.296 , Issue.5577 , pp. 2401-2403
- Vervoort, V.S.¹ Beachem, M.A.² Edwards, P.S.³ Ladd, S.⁴ Miller, K.E.⁵ De Mollerat, X.⁶ Clarkson, K.⁷ DuPont, B.⁸ Schwartz, C.E.⁹ Stevenson, R.E.¹⁰ Boyd, E.¹¹ Srivastava, A.K.¹²

75
- 0035955732
- The angiotensin II AT2 receptor is an AT1 receptor antagonist
- S. AbdAlla, H. Lother, A. M. Abdel-tawab, U. Quitterer, The angiotensin II AT2 receptor is an AT1 receptor antagonist. J. Biol. Chem. 276, 39721-39726 (2001).
- (2001) J. Biol. Chem. , vol.276 , pp. 39721-39726
- AbdAlla, S.¹ Lother, H.² Abdel-Tawab, A.M.³ Quitterer, U.⁴

76
- 65249120870
- Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease
- S. AbdAlla, H. Lother, A. el Missiry, A. Langer, P. Sergeev, Y. el Faramawy, U. Quitterer, Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J. Biol. Chem. 284, 6554-6565 (2009).
- (2009) J. Biol. Chem. , vol.284 , pp. 6554-6565
- AbdAlla, S.¹ Lother, H.² El Missiry, A.³ Langer, A.⁴ Sergeev, P.⁵ El Faramawy, Y.⁶ Quitterer, U.⁷

77
- 65249180758
- Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration
- S. AbdAlla, H. Lother, A. el Missiry, P. Sergeev, A. Langer, Y. el Faramawy, U. Quitterer, Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration. J. Biol. Chem. 284, 6566-6574 (2009).
- (2009) J. Biol. Chem. , vol.284 , pp. 6566-6574
- AbdAlla, S.¹ Lother, H.² El Missiry, A.³ Sergeev, P.⁴ Langer, A.⁵ El Faramawy, Y.⁶ Quitterer, U.⁷

78
- 0345602771
- Amyloid b Protein Toxicity Mediated by the Formation of Amyloid-b Protein Precursor Complexes
- DOI 10.1002/ana.10761
- D. C. Lu, G. M. Shaked, E. Masliah, D. E. Bredesen, E. H. Koo, Amyloid β protein toxicity mediated by the formation of amyloid-β protein precursor complexes. Ann. Neurol. 54, 781-789 (2003). (Pubitemid 37504953)
- (2003) Annals of Neurology , vol.54 , Issue.6 , pp. 781-789
- Lu, D.C.¹ Shaked, G.M.² Masliah, E.³ Bredesen, D.E.⁴ Koo, E.H.⁵

79
- 33845661843
- Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624)
- G. M. Shaked, M. P. Kummer, D. C. Lu, V. Galvan, D. E. Bredesen, E. H. Koo, Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J. 20, 1254-1256 (2006).
- (2006) FASEB J. , vol.20 , pp. 1254-1256
- Shaked, G.M.¹ Kummer, M.P.² Lu, D.C.³ Galvan, V.⁴ Bredesen, D.E.⁵ Koo, E.H.⁶

80
- 0037040889
- Amyloid β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling
- M. Yaar, S. Zhai, R. E. Fine, P. B. Eisenhauer, B. L. Arble, K. B. Stewart, B. A. Gilchrest, Amyloid β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J. Biol. Chem. 277, 7720-7725 (2002).
- (2002) J. Biol. Chem. , vol.277 , pp. 7720-7725
- Yaar, M.¹ Zhai, S.² Fine, R.E.³ Eisenhauer, P.B.⁴ Arble, B.L.⁵ Stewart, K.B.⁶ Gilchrest, B.A.⁷

81
- 61349201380
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- J. Lauren, D. A. Gimbel, H. B. Nygaard, J. W. Gilbert, S. M. Strittmatter, Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128-1132 (2009).
- (2009) Nature , vol.457 , pp. 1128-1132
- Lauren, J.¹ Gimbel, D.A.² Nygaard, H.B.³ Gilbert, J.W.⁴ Strittmatter, S.M.⁵

82
- 0024990330
- Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides
- B. A. Yankner, L. K. Duffy, D. A. Kirschner, Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250, 279-282 (1990).
- (1990) Science , vol.250 , pp. 279-282
- Yankner, B.A.¹ Duffy, L.K.² Kirschner, D.A.³

83
- 0029900084
- Amyloid β-peptide disrupts carbachol- induced muscarinic cholinergic signal transduction in cortical neurons
- J. F. Kelly, K. Furukawa, S. W. Barger, M. R. Rengen, R. J. Mark, E. M. Blanc, G. S. Roth, M. P. Mattson, Amyloid β-peptide disrupts carbachol- induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 93, 6753-6758 (1996).
- (1996) Proc. Natl. Acad. Sci. U.S.A. , vol.93 , pp. 6753-6758
- Kelly, J.F.¹ Furukawa, K.² Barger, S.W.³ Rengen, M.R.⁴ Mark, R.J.⁵ Blanc, E.M.⁶ Roth, G.S.⁷ Mattson, M.P.⁸

84
- 63449094460
- Molecular pathogenesis of Alzheimer's disease: Reductionist versus expansionist approaches
- R. J. Castellani, X. Zhu, H. G. Lee, M. A. Smith, G. Perry, Molecular pathogenesis of Alzheimer's disease: Reductionist versus expansionist approaches. Int. J. Mol. Sci. 10, 1386-1406 (2009).
- (2009) Int. J. Mol. Sci. , vol.10 , pp. 1386-1406
- Castellani, R.J.¹ Zhu, X.² Lee, H.G.³ Smith, M.A.⁴ Perry, G.⁵

85
- 57649221161
- Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: Lights and shadows
- D. Pratico, Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: Lights and shadows. Ann. N.Y. Acad. Sci. 1147, 70-78 (2008).
- (2008) Ann. N.Y. Acad. Sci. , vol.1147 , pp. 70-78
- Pratico, D.¹

86
- 0035698458
- In vivo measurement of the redox state
- D. Pratico, In vivo measurement of the redox state. Lipids 36 (suppl.), S45-S47 (2001).
- (2001) Lipids , vol.36 , Issue.SUPPL.
- D. Pratico¹

87
- 67349253085
- Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: Role of Aβ in pathogenesis
- R. Sultana, M. Perluigi, D. A. Butterfield, Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: Role of Aβ in pathogenesis. Acta Neuropathol. 118, 131-150 (2009).
- (2009) Acta Neuropathol. , vol.118 , pp. 131-150
- Sultana, R.¹ Perluigi, M.² Butterfield, D.A.³

88
- 7044274535
- Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis
- S. AbdAlla, H. Lother, A. Langer, Y. el Faramawy, U. Quitterer, Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 119, 343-354 (2004).
- (2004) Cell , vol.119 , pp. 343-354
- AbdAlla, S.¹ Lother, H.² Langer, A.³ El Faramawy, Y.⁴ Quitterer, U.⁵

89
- 0036453620
- Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease
- R. M. Bonelli, A. Aschoff, G. Niederwieser, C. Heuberger, G. Jirikowski, Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease. Neurobiol. Dis. 11, 106-110 (2002).
- (2002) Neurobiol. Dis. , vol.11 , pp. 106-110
- Bonelli, R.M.¹ Aschoff, A.² Niederwieser, G.³ Heuberger, C.⁴ Jirikowski, G.⁵

90
- 0030998670
- Transglutaminase activity is increased in Alzheimer's disease brain
- G. V. Johnson, T. M. Cox, J. P. Lockhart, M. D. Zinnerman, M. L. Miller, R. E. Powers, Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 751, 323-329 (1997).
- (1997) Brain Res. , vol.751 , pp. 323-329
- Johnson, G.V.¹ Cox, T.M.² Lockhart, J.P.³ Zinnerman, M.D.⁴ Miller, M.L.⁵ Powers, R.E.⁶

91
- 33845542144
- Activation of β2-adrenergic receptor stimulates ã- secretase activity and accelerates amyloid plaque formation
- Y. Ni, X. Zhao, G. Bao, L. Zou, L. Teng, Z. Wang, M. Song, J. Xiong, Y. Bai, G. Pei, Activation of β2-adrenergic receptor stimulates ã- secretase activity and accelerates amyloid plaque formation. Nat. Med. 12, 1390-1396 (2006).
- (2006) Nat. Med. , vol.12 , pp. 1390-1396
- Ni, Y.¹ Zhao, X.² Bao, G.³ Zou, L.⁴ Teng, L.⁵ Wang, Z.⁶ Song, M.⁷ Xiong, J.⁸ Bai, Y.⁹ Pei, G.¹⁰

92
- 60149093870
- The orphan G protein-coupled receptor 3 modulates amyloid-β peptide generation in neurons
- A. Thathiah, K. Spittaels, M. Hoffmann, M. Staes, A. Cohen, K. Horre, M. Vanbrabant, F. Coun, V. Baekelandt, A. Delacourte, D. F. Fischer, D. Pollet, B. De Strooper, P. Merchiers, The orphan G protein-coupled receptor 3 modulates amyloid-β peptide generation in neurons. Science 323, 946-951 (2009).
- (2009) Science , vol.323 , pp. 946-951
- Thathiah, A.¹ Spittaels, K.² Hoffmann, M.³ Staes, M.⁴ Cohen, A.⁵ Horre, K.⁶ Vanbrabant, M.⁷ Coun, F.⁸ Baekelandt, V.⁹ Delacourte, A.¹⁰ Fischer, D.F.¹¹ Pollet, D.¹² De Strooper, B.¹³ Merchiers, P.¹⁴

93
- 34047218120
- 5-HT4 receptor agonists increase sAPPá levels in the cortex and hippocampus of male C57BL/6J mice
- M. Cachard-Chastel, F. Lezoualc'h, I. Dewachter, C. Delomenie, S. Croes, H. Devijver, M. Langlois, F. Van Leuven, S. Sicsic, A. M. Gardier, 5-HT4 receptor agonists increase sAPPá levels in the cortex and hippocampus of male C57BL/6J mice. Br. J. Pharmacol. 150, 883-892 (2007).
- (2007) Br. J. Pharmacol. , vol.150 , pp. 883-892
- Cachard-Chastel, M.¹ Lezoualc'h, F.² Dewachter, I.³ Delomenie, C.⁴ Croes, S.⁵ Devijver, H.⁶ Langlois, M.⁷ Van Leuven, F.⁸ Sicsic, S.⁹ Gardier, A.M.¹⁰

94
- 0030028598
- Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion
- R. M. Nitsch, M. Deng, J. H. Growdon, R. J. Wurtman, Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J. Biol. Chem. 271, 4188-4194 (1996).
- (1996) J. Biol. Chem. , vol.271 , pp. 4188-4194
- Nitsch, R.M.¹ Deng, M.² Growdon, J.H.³ Wurtman, R.J.⁴

95
- 40449125903
- Distinct functional effects of human 5-HT4 receptor isoforms on β-amyloid secretion
- S. J. Robert, F. Lezoualc'h, Distinct functional effects of human 5-HT4 receptor isoforms on β-amyloid secretion. Neurodegener. Dis. 5, 163-165 (2008).
- (2008) Neurodegener. Dis. , vol.5 , pp. 163-165
- Robert, S.J.¹ Lezoualc'h, F.²

96
- 0035977026
- The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein
- S. J. Robert, J. L. Zugaza, R. Fischmeister, A. M. Gardier, F. Lezoualc'h, The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. J. Biol. Chem. 276, 44881-44888 (2001).
- (2001) J. Biol. Chem. , vol.276 , pp. 44881-44888
- Robert, S.J.¹ Zugaza, J.L.² Fischmeister, R.³ Gardier, A.M.⁴ Lezoualc'h, F.⁵

97
- 33751403136
- Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival
- S. Cho, Y. Hu, Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival. Exp. Neurol. 203, 274-278 (2007).
- (2007) Exp. Neurol. , vol.203 , pp. 274-278
- Cho, S.¹ Hu, Y.²

98
- 46749118971
- 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
- N. Upton, T. T. Chuang, A. J. Hunter, D. J. Virley, 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurotherapeutics 5, 458-469 (2008).
- (2008) Neurotherapeutics , vol.5 , pp. 458-469
- Upton, N.¹ Chuang, T.T.² Hunter, A.J.³ Virley, D.J.⁴

99
- 0038248960
- Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron
- T. Perry, D. K. Lahiri, K. Sambamurti, D. Chen, M. P. Mattson, J. M. Egan, N. H. Greig, Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron. J. Neurosci. Res. 72, 603-612 (2003).
- (2003) J. Neurosci. Res. , vol.72 , pp. 603-612
- Perry, T.¹ Lahiri, D.K.² Sambamurti, K.³ Chen, D.⁴ Mattson, M.P.⁵ Egan, J.M.⁶ Greig, N.H.⁷

100
- 3042593297
- Antagonist of the amylin receptor blocks β-amyloid toxicity in rat cholinergic basal forebrain neurons
- J. H. Jhamandas, D. MacTavish, Antagonist of the amylin receptor blocks β-amyloid toxicity in rat cholinergic basal forebrain neurons. J. Neurosci. 24, 5579-5584 (2004).
- (2004) J. Neurosci. , vol.24 , pp. 5579-5584
- Jhamandas, J.H.¹ MacTavish, D.²

101
- 77953679713
- This project was supported by a Methusalem grant from the Flemish government, the Fund for Scientific Research (Flanders, Belgium), and the Federal Office for Scientific Affairs (IUAP P6/43/), Belgium
- This project was supported by a Methusalem grant from the Flemish government, the Fund for Scientific Research (Flanders, Belgium), and the Federal Office for Scientific Affairs (IUAP P6/43/), Belgium.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.